Registry Stop Signal

Carboplatin

Carboplatin is flagged as registry stop signal because public records show a registry stop signal, timeline staleness, public results not found after completion, operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.

Program overview

Context

Indication: Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8

Mechanism: Unknown

Modality: Unknown

Sponsor: City of Hope Medical Center

Scores

Risk-signal summary

Registry: 5/5

Timeline: 2/5

Recruitment burden: 2/5

Results availability: 3/5

Program risk: 5/5

Evidence

Public links

https://clinicaltrials.gov/study/NCT04929392 | https://clinicaltrials.gov/study/NCT00005976 | https://clinicaltrials.gov/study/NCT05952453 | https://clinicaltrials.gov/study/NCT03442556 | https://clinicaltrials.gov/study/NCT00303849

Linked trials

Trial-level signal details

TrialStatusTimelineResultsBurden
NCT04929392Low Signal (ACTIVE_NOT_RECRUITING)primary_completion_date_past_signal | long_recruitment_duration_signalLow Signalrare_population_signal | strict_eligibility_signal
NCT00005976Low Signal (COMPLETED)stale_update_signalCompleted No Results Found SignalNone
NCT05952453Low Signal (RECRUITING)NoneLow Signalrare_population_signal | strict_eligibility_signal
NCT03442556Registry Stop Signal (TERMINATED)stale_update_signalLow Signalrare_population_signal
NCT00303849Low Signal (COMPLETED)stale_update_signalCompleted No Results Found Signalstrict_eligibility_signal